Episode # 153 • 27 Feb 2024
Precision Medicine in Prostate Cancer
In this episode, Dr. Edward Schaeffer, chair of urology at Feinberg School of Medicine, discusses precision medicine in prostate cancer with Dr. Aditya Bagrodia.
Timestamps
00:00 - Introduction
10:32 - Precision Medicine and Prostate Cancer
16:17 - Screening and Diagnosis of Prostate Cancer
29:41 - Personalizing Surveillance and Disease Management
33:11 - The Role of Genomic Testing in Prostate Cancer
45:00 - The Use of PET PSMA Scans in Prostate Cancer Staging
48:08 - The Future of Precision Medicine in Prostate Cancer
You may also like
More about this episode
First, Dr. Schaeffer introduces the importance of using a defined screening strategy for prostate cancer that includes analyzing a patient’s genomic and germline risk. Then, he summarizes existing and new diagnostic tools for prostate cancer. Additionally, Dr. Schaeffer discusses genomic testing and PSMA testing and explains how he applies them to individual patient cases depending on their cancer stage and grade. Finally, the doctors highlight the ability of future tools, like PET PSMA scans, to advance precision medicine.
The Materials available on BackTable are provided for informational and educational purposes only and are not a substitute for the independent professional judgment of a qualified healthcare professional in diagnosing or treating patients. Any opinions, statements, or views expressed are those of the individual contributors and do not necessarily reflect those of the publisher, platform, or any affiliated organization.